Nuvation Bio Inc. (NUVB) Reports In-Line Q2 EPS

Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $4.83 million versus the consensus estimate of $416.67 thousand.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
• Crusoe in talks to raise $3B in funding - Bloomberg